Back

Physiological determinants underlying a meaningful improvement in VO2peak following exercise training in anthracycline-treated breast cancer survivors

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Managing cardiovascular risk in cancer patients Cardio-Oncology Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Stephen Foulkes

St. Vincent's Institute of Medical Research, Fitzroy (Australia)

4 More presentations in this session

Presentation thumbnail
Cardiac rehabilitation and long-term prognosis in cardiovascular disease patients with cancer history
Mr T. Miki (Sagamihara, JP)
Abstract Slides
Presentation thumbnail
Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.
Doctor J. Meng (Norwich, GB)
Abstract Slides
Presentation thumbnail
Cardiovascular health profile of cancer survivors: real-world insights from the Polish Norwegian Study (PONS)
Doctor G. Vaidean (Miami, US)
Abstract Slides
Presentation thumbnail
Peak oxygen uptake impairment in childhood cancer survivors treated with anthracycline-based chemotherapy: a systematic-review and meta-analysis
Doctor S. Foulkes (Fitzroy, AU)
Abstract Slides

Access the full session

Session thumbnail
Managing cardiovascular risk in cancer patients

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources